Vacuna Patria: At the end of this year, its emergency use would have been approved in Mexico

The Director General of the National Council of Science and Technology (Conacyt), María Elena Álvarez-Buylla Roces, presented a report on the development of the Mexican COVID-19 vaccine, which will be called Patria. He pointed out that it has already been tested on animals and is safe, and now the phase of testing on volunteers will begin.

“Scientists at the highest level are involved in the creation of the Patria vaccine, Avimex company and public institutes, it is safe for animals and we are going to start recruiting volunteers ”, said the director of Conacyt.

| The phase 1 clinical trial of the Patria vaccine has already started and is in the “recruiting” phase. Between 90 and 100 healthy adult volunteers will be recruited in Mexico City and results are expected by the end of May.O.

The “Patria” vaccine would be ready by the end of this year if all the processes required by the Mexican health authority are followed, he said. Alvarez-Buylla.

“If all goes according to plan, we will have a vaccine by the end of the year at the end of this year for approval for emergency use by Cofepris.”

“The start of recruiting volunteers is what we are announcing right now.”

The drug, which has already been tested in rodents and pigs, uses a Newcastle disease viral vector, which “is not harmful to humans,” the Conacyt official explained.

According to the report of Alvarez-Buylla andanalysis of the results of Phase 1 They will take place between April and May; the Phase 2, for June-July, while the Phase 3 it is scheduled between August and October of this year.

“There is still the development of the three phases of clinical studies where also there is uncertainty, but we are convinced that it will become a Mexican vaccine development that will allow us to defend ourselves against covid-19 ”.

It is estimated that between November and December it will be presented at the Cofepris for your emergency use authorization.

During the morning press conference of President Andrés Manuel López Obrador, the director of Conacyt announced “the start of the recruitment of volunteers”, between 90 and 100 in Mexico City, for clinical studies of Patria, a vaccine developed by the Avimex laboratory and the Mexican government.

Álvarez-Buylla said that “it is very difficult” to get to the point where the Patria vaccine has arrived, since only between 10 and 20% of vaccines start clinical trials, which is why he considers this “great news”.

Renowned scientists such as doctors Constantino López Macías, Peter Palese, Adolfo García-Sastre, Florian Krammer, Felipa Castro and Martha Torres Rojas are involved in the development of Homeland, said the director of Conacyt.

Although several Mexican universities are trying to develop a drug against covid-19, the Mexican government has opted for the Patria vaccine, named after López Obrador himself in reference to the Sovereign vaccine developed in Cuba.

Mexico was on December 24, 2020 one of the first countries to start vaccinating, and since then it has applied 11.8 million doses, while 2.3 million people have received the two doses needed for vaccination, mainly the elderly and health workers.

The country of 126 million people received 16,413,350 vaccines in total from the United States Pfizer, Britain’s AstraZeneca, Chinese Sinovac, Russian Sputnik V and Chinese CanSino.

KEEP READING: